balance equationreview2025-12-31
Difference 5542488 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
Revenue
$11.54M
Fiscal year ended 2025-12-31Operating income
$1.10M
Fiscal year ended 2025-12-31Free cash flow
Unavailable
Fiscal year ended 2025-12-31Cardiff Lexington Corp (CDIX) reported revenue of $11.54M and net income of -$5.51M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Cardiff Lexington Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.54M | $8.27M | $11.85M | $10.69M | $9.88M | $3.45M | $3.71M | $2.23M | $1.63M | $1.15M |
| Cost of revenue | $4.33M | $3.84M | $3.56M | $4.06M | $3.77M | $1.67M | $1.67M | $1.47M | $1.43M | $797.07K |
| Gross profit | $7.21M | $4.43M | $8.29M | $6.63M | $6.11M | $1.78M | $2.04M | $755.83K | $193.86K | $353.18K |
| Operating income | $1.10M | -$193.50K | $5.20M | $3.91M | $1.66M | -$1.80M | -$1.27M | -$2.02M | -$2.99M | -$2.16M |
| Net income | -$5.51M | -$3.30M | $3.03M | -$5.43M | $666.29K | -$2.84M | -$7.18M | -$6.27M | -$3.65M | -$2.25M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 8.50M | shares 3.82M | shares 15.00K | shares 5.82K | shares 128.02M | shares 908.48K | shares 25.40K | Unavailable | Unavailable | Unavailable |
| Pretax income | -$5.75M | -$3.19M | $3.11M | -$3.25M | -$303.61K | -$2.92M | -$6.03M | Unavailable | Unavailable | Unavailable |
| Income tax expense | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Diluted EPS | Unavailable | Unavailable | Unavailable | Unavailable | $-0.01 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | $5.33M | $4.06M | $3.08M | $2.70M | $4.43M | $3.59M | $3.31M | $2.76M | $2.06M | $2.51M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $279.31K | Unavailable | $158.68K | $207.89K | $62.95K |
| Total assets | $29.09M | $23.93M | $20.75M | $13.34M | $15.30M | $4.93M | $4.92M | $3.33M | $1.32M | $2.47M |
| Current assets | $22.59M | $17.21M | $14.18M | $6.83M | $6.59M | $295.69K | $186.68K | $277.21K | $190.61K | $174.18K |
| Total liabilities | $26.01M | $16.32M | $14.12M | $10.19M | $11.44M | $13.80M | $11.64M | $8.18M | $4.75M | $4.07M |
| Current liabilities | $25.83M | $15.89M | $13.86M | $9.96M | $11.17M | $13.40M | $10.75M | $7.14M | $4.75M | $4.07M |
| Total equity incl. NCI | -$2.47M | $2.69M | $731.42K | -$1.74M | $486.84K | -$8.87M | -$6.73M | -$4.85M | -$3.43M | -$1.60M |
| Temporary (mezzanine) equity | Unavailable | $4.92M | $5.89M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $3.08K | $3.08K | $46.93K | $42.23K |
| Accounts receivable | $22.07M | $15.93M | $13.31M | $6.60M | $6.01M | $16.38K | $99.54K | $64.34K | $63.06K | $32.01K |
| Goodwill | $5.67M | $5.67M | $5.67M | $5.67M | $7.76M | $7.76M | $3.50M | $2.09M | $0 | $932.53K |
| Long-term debt | $18.56M | $9.21M | $2.28M | $155.60K | $600.93K | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts payable | $1.09M | $684.32K | $720.77K | $342.33K | $170.91K | $119.65K | $228.97K | $359.29K | $206.74K | $65.90K |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | Unavailable | Unavailable | -$1.72M | -$1.15M | Unavailable | Unavailable | -$1.05M | -$1.10M | -$614.90K | -$198.14K |
| Capital expenditures | Unavailable | Unavailable | Unavailable | $0 | $3.41K | $0 | Unavailable | $852.00K | $0 | $18.66K |
| Investing cash flow | Unavailable | Unavailable | Unavailable | $0 | -$2.32M | Unavailable | $32.45K | -$760.15K | -$12.80K | $12.97K |
| Financing cash flow | $1.98M | $2.98M | $2.37M | $788.79K | $3.68M | $1.15M | $717.86K | $1.81M | $633.74K | $176.52K |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -$17.53K | -$49.22K | $6.04K | -$8.64K |
| Stock-based compensation | $754.48K | $544.72K | $0 | Unavailable | Unavailable | Unavailable | $0 | $287.47K | $285.62K | $1.02M |
| Common dividends paid | $50.00K | $100.00K | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $5.65K | $13.46K | $20.78K | $23.13K | $13.89K | $23.10K | $67.70K | $79.30K | $227.96K | $174.86K |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -$614.90K | -$216.80K |
| Gross margin | 62.5% | 53.5% | 70.0% | 62.0% | 61.9% | 51.7% | 55.1% | 33.9% | 11.9% | 30.7% |
| Operating margin | 9.5% | -2.3% | 43.8% | 36.5% | 16.8% | -52.2% | -34.3% | -90.8% | -184.1% | -188.2% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -37.8% | -18.8% |
| SBC / revenue | 6.5% | 6.6% | 0.0% | Unavailable | Unavailable | Unavailable | Unavailable | 12.9% | 17.6% | 88.7% |
| Current ratio | 0.87x | 1.08x | 1.02x | 0.69x | 0.59x | 0.02x | 0.02x | 0.04x | 0.04x | 0.04x |
| Revenue YoY growth | 39.5% | -30.2% | 10.8% | 8.2% | 186.1% | -6.9% | 66.5% | 37.0% | 41.3% | Unavailable |
| Net margin | -47.7% | -39.9% | 25.5% | -50.8% | 6.7% | -82.2% | -193.7% | -281.3% | -224.6% | -196.0% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | 0.0% | 0.0% | Unavailable | Unavailable | 0.0% | 1.6% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CDIX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-12View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-10View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q/A · Filed 2025-08-19View SEC filing
10-Q/A · Filed 2025-08-19View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2022-12-31
Difference 4899984 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2021-12-31
Difference 3370524 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.